QBN-24077-11844
3 vaccinations
9 coded responses
27 check-ins
9 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 781 / TX
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- KAK-75651-44231
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Pfizer-BioNTech
-
2022-06-26
Registered in v-safe
- 2022-06-26
- 2022-06-27
- 2022-06-29
- 2022-07-06
-
2022-07-13
Survey response — day 21, dose 1, under 3MedDRA: COVID-19, Cough, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive for covid today Cough and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Survey response — day 28, dose 1, under 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
-
2022-07-25
Dose 2 — Pfizer-BioNTech
-
2022-07-27
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-07-28
-
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Rash, not including the immediate area around the injection siteUnder 3 check-in
-
2022-07-30
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Rash, not including the immediate area around the injection siteUnder 3 check-in
-
2022-08-01
Health check-in — day 7, dose 2, under 3Feeling: Good · Rash, not including the immediate area around the injection siteUnder 3 check-in
- 2022-08-08
- 2022-08-17
- 2022-08-22
-
2022-08-29
Survey response — day 35, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: PoorFree text: Cough and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-05
Survey response — day 42, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: Cold with cough and runny nose Negative for covid on home rapid testMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-24
-
2022-09-25
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: Fair · Irritability/cryingFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Survey response — day 7, dose 3, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · SleepinessFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Survey response — day 14, dose 3, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-11
Survey response — day 21, dose 3, under 3MedDRA: Cough, Periorbital swelling, Rhinorrhoea — Feeling: FairFree text: Runny nose, cough, puffy eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Pfizer-BioNTech | No |
| 2 | 2022-07-25 | Pfizer-BioNTech | No |
| 3 | 2022-09-20 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Positive for covid today Cough and congestion
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Covid positive
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Cough and runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Cold with cough and runny nose Negative for covid on home rapid test
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose and cough
Release 12 (Under 3) — day 7, dose 3, under 3
Systemic reaction (other): Runny nose and cough
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Runny nose and cough
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Runny nose, cough, puffy eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Periorbital swelling | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release